ENCEPHALITIS
Encephalitis = inflammation of brain parenchyma associated with neurological dysfunction
Distinguished from:
- Meningitis → meningeal inflammation
- Meningoencephalitis → overlap
EPIDEMIOLOGY
- Incidence: ~5–10 per 100,000/year
- High mortality: HSV encephalitis ~20–30% even with treatment
- Seasonal patterns:
- Summer/monsoon (India) → arboviruses (JE, dengue, chikungunya)
- Winter → viral respiratory-related encephalitis
- Age groups:
- Neonates → HSV, enterovirus
- Children → JE, autoimmune
- Adults → HSV, autoimmune, TB
ETIOLOGY
INFECTIOUS CAUSES
Viral (MOST COMMON)
- Herpes simplex encephalitis ( MOST IMPORTANT)
- Japanese encephalitis
- Rabies
- Varicella zoster encephalitis
- Enteroviruses (Coxsackie, Echo)
- Arboviruses (West Nile, dengue)
- COVID-19
Bacterial
- Tuberculous encephalitis
- Listeria monocytogenes infection
- Neurosyphilis
- Brain abscess-related inflammation
Parasitic / Fungal
- Cerebral malaria
- Toxoplasmosis
- Cryptococcosis
AUTOIMMUNE ENCEPHALITIS
- Anti-NMDA receptor encephalitis
- LGI1, CASPR2
- Paraneoplastic (small cell lung cancer)
POST-INFECTIOUS / PARA-INFECTIOUS
- Acute disseminated encephalomyelitis
PATHOPHYSIOLOGY
Mechanisms
- Direct viral invasion
- HSV → temporal lobe necrosis
- Immune-mediated injury
- Autoantibodies against neuronal receptors
- Cytokine storm
- BBB disruption
- Cerebral edema → raised ICP
HSV ENCEPHALITIS
- Temporal lobe involvement
- Hemorrhagic necrosis
- Personality changes + seizures
CLINICAL FEATURES
CLASSIC TRIAD
- Fever
- Altered mental status
- Seizures
|
Category |
Features |
|
General |
Fever, headache |
|
Neurological |
Confusion, coma |
|
Seizures |
Focal or generalized |
|
Focal deficits |
Aphasia, hemiparesis |
|
Behavioral |
Psychosis (NMDA) |
|
Raised ICP |
Vomiting, papilledema |
|
Movement disorders |
Dyskinesia (NMDA) |
|
Virus |
When to Suspect |
|
Herpes simplex virus type 1 |
Most common; acute fever + altered behavior + seizures; temporal lobe signs (aphasia, personality change); MRI: temporal hyperintensity; CSF RBCs present (hemorrhagic necrosis) |
|
Herpes simplex virus type 2 |
Neonates, immunocompromised; meningitis > encephalitis; genital herpes history |
|
Varicella zoster virus |
Recent shingles (dermatomal rash); stroke-like deficits (vasculopathy); elderly/immunocompromised |
|
Japanese encephalitis virus |
Rural Asia/India; mosquito exposure; movement disorders (parkinsonism); MRI: bilateral thalamic lesions |
|
West Nile virus |
Fever + encephalitis + acute flaccid paralysis (anterior horn cell); elderly; mosquito exposure |
|
Dengue virus |
Dengue features: thrombocytopenia, rash, plasma leakage; encephalopathy ± encephalitis |
|
Chikungunya virus |
Severe polyarthralgia + fever + neuro symptoms |
|
Rabies virus |
Animal bite history; hydrophobia, aerophobia, agitation; fatal once symptomatic |
|
Cytomegalovirus |
AIDS/transplant; periventricular lesions; retinitis association |
|
Epstein-Barr virus |
Infectious mononucleosis features; lymphadenopathy; mild encephalitis |
|
Human herpesvirus 6 |
Post-transplant; limbic encephalitis (memory loss, seizures) |
|
Enteroviruses |
Children; summer outbreaks; aseptic meningitis ± encephalitis |
|
Influenza virus |
Recent flu illness; encephalopathy more common than true encephalitis |
|
Organism / Disease |
When to Suspect |
|
Streptococcus pneumoniae |
Most common adult meningitis; acute fever + altered sensorium; CSF: neutrophils↑, protein↑, glucose↓; may follow pneumonia/otitis |
|
Neisseria meningitidis |
Young adults + outbreaks; petechial rash, septic shock (Waterhouse–Friderichsen) |
|
Listeria monocytogenes |
Elderly, pregnancy, immunocompromised; brainstem signs; ampicillin needed (resistant to cephalosporins) |
|
Haemophilus influenzae |
Unvaccinated children; respiratory infection history |
|
Mycobacterium tuberculosis |
Subacute (weeks); fever + headache + cranial nerve palsy; basal meningitis, hydrocephalus; CSF: lymphocytes↑, protein very high, glucose very low |
|
Staphylococcus aureus |
Post-neurosurgery/trauma; brain abscess (ring lesion) |
|
Streptococcus milleri group |
Dental/sinus infection → brain abscess |
|
Nocardia species |
Immunocompromised; multiple brain abscesses |
|
Brucella species |
Endemic areas (India); chronic meningitis + neuropsychiatric features |
|
Leptospira interrogans |
Exposure to contaminated water; fever + jaundice + aseptic meningitis |
|
Parasite |
When to Suspect |
|
Taenia solium |
Most common parasitic CNS infection in India; seizures; multiple ring lesions with scolex(“hole-with-dot”) |
|
Plasmodium falciparum |
Fever + coma + seizures; malaria endemic area; retinal hemorrhages, severe anemia |
|
Toxoplasma gondii |
AIDS (CD4 <100); multiple ring-enhancing lesions (basal ganglia); responds to pyrimethamine + sulfadiazine |
|
Naegleria fowleri |
Freshwater exposure; rapidly fatal, resembles bacterial meningitis; neutrophils in CSF but no bacteria |
|
Acanthamoeba species |
Subacute in immunocompromised; focal deficits + encephalopathy |
|
Echinococcus granulosus |
Large cystic brain lesion; raised ICP; endemic livestock exposure |
|
Trypanosoma brucei |
Sleep disturbance, neuropsychiatric symptoms (“sleeping sickness”) |
|
Angiostrongylus cantonensis |
Eosinophils in CSF; snail/raw food exposure |
DIFFERENTIAL DIAGNOSIS
- Meningitis
- Brain abscess
- Stroke
- Status epilepticus
- Metabolic encephalopathy
DIAGNOSIS
International Encephalitis Consortium criteria
Encephalitis = inflammation of brain parenchyma with:
- Altered mental status ≥24 hours (mandatory)
PLUS ≥2 of: - Fever ≥38°C
- Seizures
- New focal neurological deficit
- CSF pleocytosis
- EEG abnormalities
- Neuroimaging suggestive
INITIAL WORKUP
BEFORE LP (if needed)
- ABC stabilization
- Blood glucose
- Electrolytes
- Sepsis workup
IMMEDIATE TESTS
- CBC, CRP, ESR
- LFT, RFT
- Blood cultures ×2
- HIV testing
- Malaria, dengue (India-specific)
LUMBAR PUNCTURE
Contraindications BEFORE LP
- Papilledema
- Focal deficit
- Immunocompromised
- GCS < 10
Do CT/MRI first
A. CSF ANALYSIS (About 10% of patients will have normal CSF studies.)
|
Parameter |
Viral |
Bacterial |
TB |
Fungal |
Autoimmune |
|
Opening pressure |
Normal/↑ |
↑↑ |
↑ |
↑ |
Normal |
|
Cells |
Lymphocytes |
Neutrophils |
Lymphocytes |
Lymphocytes |
Mild |
|
Protein |
Mild ↑ |
↑↑ |
↑↑ |
↑ |
Mild ↑ |
|
Glucose |
Normal |
↓ |
↓ |
↓ |
Normal |
B. CSF-SPECIFIC TESTS
Gold Standard Tests
- PCR (MOST IMPORTANT)
- HSV-1, HSV-2
- VZV
- Enterovirus
- CMV (immunocompromised)
HSV PCR = gold standard for Herpes Simplex Encephalitis
Additional CSF Tests
- CSF culture (bacterial)
- CSF ADA (TB)
- Cryptococcal antigen
- GeneXpert (TB)
C. Autoimmune Encephalitis Workup
- Anti-NMDA receptor antibodies
- Anti-LGI1, CASPR2
- GABA-B antibodies
Classic: Anti-NMDA receptor encephalitis
NEUROIMAGING
A. CT Brain (Initial)
- Rule out:
- Mass lesion
- Hemorrhage
- Raised ICP
Often normal early
B. MRI Brain (GOLD STANDARD)
Typical MRI Findings
|
Etiology |
MRI Findings |
|
HSV |
Temporal lobe hyperintensity(usually appear 3-5 day after the infection.) |
|
Autoimmune |
Limbic system involvement |
|
Japanese encephalitis |
Thalamus |
|
Rabies |
Brainstem |
EEG
|
Pattern |
Suggests |
|
Periodic lateralized epileptiform discharges (PLEDs) |
HSV encephalitis |
|
Diffuse slowing |
Encephalopathy |
|
Seizure activity |
Nonconvulsive status |
EEG helps in:
- Detecting subclinical seizures
- Supporting HSV diagnosis
MANAGEMENT
1. INITIAL APPROACH (FIRST GOLDEN HOURS)
A. ABC + NEUROCRITICAL CARE PRIORITIES
- Airway
- Intubate if:
- GCS ≤ 8
- Refractory seizures
- Severe agitation
- Raised ICP with risk of herniation
- Breathing
- Target SpO₂ > 94%
- Avoid hypercapnia (↑ ICP)
- Circulation
- Maintain MAP ≥ 65 mmHg
- Avoid hypotension (↓ cerebral perfusion pressure)
B. IMMEDIATE EMPIRICAL THERAPY (DO NOT WAIT FOR CSF)
Start within 1 hour of suspicion
1. ANTIVIRAL (MANDATORY)
- Acyclovir
- Dose: 10 mg/kg IV q8h
- Duration:
- HSV: 14–21 days
- Adjust for renal function
2. ANTIBIOTICS (IF MENINGOENCEPHALITIS NOT EXCLUDED)
- Ceftriaxone 2 g IV q12h
- Vancomycin (trough-based dosing)
- Add:
- Ampicillin (if >50 yrs / immunocompromised → cover Listeria)
3. CONSIDER ADDITIONAL ANTIVIRALS
- Ganciclovir ± foscarnet
- If CMV suspected (immunocompromised)
2. TARGETED ETIOLOGY-SPECIFIC THERAPY
A. VIRAL ENCEPHALITIS
1. HSV encephalitis (MOST IMPORTANT EXAM POINT)
- Drug: Acyclovir
- Duration:
- 14–21 days
- Repeat CSF PCR if:
- No improvement
2. Varicella Zoster Virus (VZV)
- Acyclovir 10–15 mg/kg IV q8h
- ± steroids (controversial, for vasculopathy)
3. Japanese Encephalitis (common in India)
- No specific antiviral
- Pure supportive ICU care
4. CMV Encephalitis
- Ganciclovir 5 mg/kg IV every 12 hours + Foscarnet 60 mg/kg IV every 8 hours or 90 mg/kg IV every 12 hours for 21 days.
5. Arboviruses (Dengue, West Nile)
- Supportive only
B. BACTERIAL (MENINGOENCEPHALITIS)
- Treat as meningitis initially
- Modify after CSF culture
C. TUBERCULAR ENCEPHALITIS
- ATT (HRZE regimen) + steroids
D. FUNGAL ENCEPHALITIS
- Amphotericin B
- Followed by:
- Fluconazole
E. AUTOIMMUNE ENCEPHALITIS
Examples:
- Anti-NMDA receptor
- LGI1, CASPR2
Treatment:
- First line
- IV methylprednisolone (1 g/day × 5 days)
- IVIG OR plasmapheresis
- Second line
- Rituximab
- Cyclophosphamide
3. MANAGEMENT OF COMPLICATIONS
A. SEIZURE MANAGEMENT
- 1st line: Lorazepam
- 2nd line:
- Levetiracetam
- Phenytoin
Refractory seizures:
- Midazolam infusion
- Propofol infusion
B. RAISED ICP MANAGEMENT
General Measures:
- Head elevation: 30°
- Neutral neck
- Avoid fever, hypoxia, hypercapnia
Osmotherapy:
- Mannitol
- 0.25–1 g/kg IV bolus
- OR hypertonic saline
Advanced:
- Sedation (propofol)
- Controlled ventilation (PaCO₂ 35 mmHg)
- Barbiturate coma (last resort)
